Prueba de HbA1c en el punto de atención
Prueba de HbA1c en el punto de atención
Comunicate con el proveedor:
!noticia guardada!
- Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004;141:413–20.
- Selvin E, Marinopoulos S, Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann of Internal Medicine 2004;141:421–31.
- ten Brinke R, Dekker N, de Groot M, Ikkersheim D. Lowering HbA1c in type 2 diabetics results in reduced risk of coronary heart disease and all cause mortality. Prim Care Diabetes 2008;2:45–9.2.Selvin E, Marinopoulos S, Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann of Internal Medicine 2004;141:421–31.
- Diabetes UK. HbA1c Standardisation: Information for Clinical Healthcare Professionals. 2009.
- Snellman K, Eckerborn S. Possibilities and advantages of HbA1c: eight years experience. Diabet Med 1997; 14(5): 401-403.
- Plüddemann A, Price CP, Thomson M, Wolsteholme J, Heneghan C. British Journal of General Practice 2011; 61: 139-140.
- Grieve R, Beech R, Vincent J, Mazurkiewcz J. Near patient testing in diabetes clinics: appraising the cots and outcomes. Health Technol Assess 1999; 3:1-74
- Ferenczi A, Reddy K, Lorber DL. Effect of immediate hemoglobin A1c results on treatment decisions in office practice. Endocr Pract 2001;7:85–8.
- Petersen JR, Finley JB, Okorodudu AO, Mohammad AA, Grady JJ, Bajaj M. Effect of point-of-care on maintenance of glycemic control as measured by A1C. Diabetes Care 2007;30:713–5.
- Rust G, Gailor M, Daniels E, McMillan-Persaud B, Strothers H, Mayberry R. Point of care testing to improve glycemic control. Int J Health Care Qual Assur 2008;21:325–35.
- Driskell OJ, Holland D, Hanna FW, Jones PW, Pemberton RJ, Tran M, Fryer AA. Inappropriate requesting of glycated hemoglobin (Hb A1c) is widespread: assessment of prevalence, impact of national guidance, and practice-to-practice variability. Clin Chem 2012;58:906-15.
- Peterson KA, Radosevich DM, O'Connor PJ, Nyman JA, Prineas RJ, Smith SA, et al. Improving Diabetes Care in Practice: findings from the TRANSLATE trial. Diabetes Care 2008;31:2238-43
- Laurence CO, Gialamas A, Bubner T, Yelland L, Willson K, Ryan P, Beilby J. Point of Care Testing in General Practice Trial Management Group. Patient satisfaction with point-of-care testing in general practice. Br J Gen Pract 2010;60:e98–104.
- Cagilero E, Levina EV, Nathan DM. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999; 22(11): 1785-1789.
- Miller CD, Barnes CS, Phillips LS, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 2003; 26(4): 1158-1163.
- Kennedy L, Herman WH, Strange P, et al. GOAL A!C Team. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 2006; 29(1): 1-8.
- Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 2007;24:333-43.
- Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
- World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. 2011. [online]
- National Institute for Health and Clinical Excellence. Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. 2012. [online]
- American Diabetes Association. International Expert Committee Report on the role of the A1C Assay in the diagnosis of diabetes. Diabetes Care 2009; 32 (7):1327-1334.
- Inzucchi SE. Clinical practice. Diagnosis of diabetes. N Engl J Med 2012;367:542-50.
- Farmer A. Use of HbA1c in the diagnosis of diabetes. BMJ 2012;345:e7293.
- Geistanger A, Arends S, Berding C, Hoshino T, Jeppsson JO, Little R, Siebelder C, Weykamp C; on behalf of the IFCC Working Group on Standardization of Hemoglobin A1c. Statistical Methods for Monitoring the Relationship between the IFCC Reference Measurement Procedure for Hemoglobin A1c and the Designated Comparison Methods in the United States, Japan, and Sweden. Clin Chem. 2008 Aug;54(8):1379-85.
- Wilson DH, Bogacz JP, Forsythe CM, Turk PJ, Lane TL, Gates RC and Brandt DR. Fully automated assay of glycohemoglobin with the Abbott IMx analyzer: novel approaches for separation and detection. Clinical Chemistry October 1993 vol. 39 no. 10 2090-2097
Te podría interesar...
Lo más leído
El hospital militar Burdenko en Moscú ha logrado desarrollar una tecnología en base a la i...
La sonografía se presenta como una alternativa valiosa para la proyección de imágenes comp...
Los mejores Hospitales de Latino América, son reconocidos por su excelencia médica y tecno...
Estos elementos, más allá de ser indispensables para cumplir la normatividad, protegen a l...
Notas recomendadas por el editor
27/07/2022
Nueva alianza B&A: Biomedicos Asociados LTDA
B&A Biomedicos Asociados LTDA, empresa establecida en Colombia desde 2004, tiene el gusto de presentar la nueva alianza creada con Amico Corporati
27/07/2022
Humidificador electrónico Airvo 2
El Airvo 2 establece un nuevo estándar para la administración de la terapia de flujo nasal alto, proporcionando rendimiento y comodidad
27/07/2022
Asuntos regulatorios en Colombia: ¡un paraíso!
Adicional al magnífico clima, naturaleza exuberante y la belleza de nuestra gente, Colombia ofrece ventajas altamente competitivas para las emp